Karin Sundström

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Jag är cancerepidemiolog och forskargruppsledare på KI. Min forskning kretsar kring humant papillomvirus (HPV) och de cancerformer som detta virus orsakar, främst livmoderhalscancer (cervixcancer). Jag forskar även på biomarkörer för att diagnosticera äggstockscancer (ovarialcancer) samt cancer i livmoderkroppen (endometriecancer).

För mer information om mig och min forskning var vänlig se min sida på engelska!

Artiklar

Article: MATURITAS. 2024;185:108009
Antidepressant use and ovarian cancer risk: Evidence from nationwide studies with >14,000 cases from Denmark and Sweden
Zheng G; Baandrup L; Wang J; Hertzum-Larsen R; Hannibal CG; Morch LS; Faber MT; Sundstrom K; Kjaer SK
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2024;52(5):616-623
Factors associated with teenage pregnancy in the Scandinavian countries
Bennetsen AKK; Faber MT; Nygaard M; Sundstrom K; Hansen BT; Thomsen LT; Munk C; Frederiksen K; Kjaer SK
Article: BRITISH JOURNAL OF CANCER. 2024;130(8):1279-1285
Low-dose aspirin use and risk of ovarian cancer: a combined analysis from two nationwide studies in Denmark and Sweden
Zheng G; Faber MT; Wang J; Baandrup L; Hertzum-Larsen R; Sundstrom K; Kjaer SK
Article: JOURNAL OF MEDICAL ECONOMICS. 2024;27(sup2):9-19
Global burden and economic impact of vaccine-preventable cancer mortality
Bencina G; Oliver E; Meiwald A; Hughes R; Morais E; Weston G; Sundstrom K
Article: PLOS MEDICINE. 2024;21(3):e1004372
Incidence of oncogenic HPV infection in women with and without mental illness: A population-based cohort study in Sweden
Herweijer E; Hu K; Wang J; Lu D; Sparen P; Adami H-O; Valdimarsdottir U; Sundstroem K; Fang F
Article: PREVENTIVE MEDICINE REPORTS. 2023;35:102342
High coverage and adherence to dose intervals of the national school-based HPV vaccination program in Sweden during 2012-2019
Wang J; Herweijer E; Kleppe SN; Hartwig S; Velicer C; Koro C; Sundstrom K
Article: PLOS MEDICINE. 2023;20(10):e1004304
Impact of cervical screening by human papillomavirus genotype: Population-based estimations
Wang J; Elfstrom KM; Lagheden C; Eklund C; Sundstrom K; Sparen P; Dillner J
Journal article: ANNALS OF ONCOLOGY. 2023;34:s539
Mental and socioeconomic burden in co-parents and children of patients with endometrial and cervical cancer: A Swedish population-based study
Sundstrom K; Bencina G; Andersson M; Salomonsson S; Fang F; Wang J
Article: JAMA NETWORK OPEN. 2023;6(9):e2336213
Overall and Cervical Cancer Survival in Patients With and Without Mental Disorders
Herweijer E; Wang J; Hu K; Valdimarsdottir UA; Adami H-O; Sparen P; Sundstrom K; Fang F
Article: INTERNATIONAL JOURNAL OF CANCER. 2023;152(11):2321-2330
HPV-induced host epigenetic reprogramming is lost upon progression to high-grade cervical intraepithelial neoplasia
Herzog C; Vavourakis CDD; Barrett JEE; Karbon G; Villunger A; Wang J; Sundstrom K; Dillner J; Widschwendter M
Article: INTERNATIONAL JOURNAL OF CANCER. 2023;152(9):1977-1988
The WID-EC test for the detection and risk prediction of endometrial cancer
Barrett JE; Jones A; Evans I; Herzog C; Reisel D; Olaitan A; Mould T; MacDonald N; Doufekas K; Newton C; Crosbie EJ; Bjorge L; Colombo N; Dostalek L; Costas L; Peremiquel-Trillas P; Ponce J; Matias-Guiu X; Zikan M; Cibula D; Wang J; Sundstroem K; Dillner J; Widschwendter M
Article: LANCET PUBLIC HEALTH. 2023;8(4):e266-e275
Invasive cervical cancer, precancerous lesions, and cervical screening participation among women with mental illness in Sweden: a population-based observational study
Hu K; Wang J; Sparen P; Herweijer E; Sjolander A; Adami H-O; Valdimarsdottir U; Sundstrom K; Fang F
Article: CLINICAL EPIGENETICS. 2022;14(1):150
DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test
Herzog C; Sundstrom K; Jones A; Evans I; Barrett JE; Wang J; Redl E; Schreiberhuber L; Costas L; Paytubi S; Dostalek L; Zikan M; Cibula D; Sroczynski G; Siebert U; Dillner J; Widschwendter M
Article: JOURNAL OF CLINICAL ONCOLOGY. 2022;40(33):3828-3838
A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets
Herzog C; Marin F; Jones A; Evans I; Reisel D; Redl E; Schreiberhuber L; Paytubi S; Pelegrina B; Carmona A; Peremiquel-Trillas P; Frias-Gomez J; Pineda M; Brunet J; Ponce J; Matias-Guiu X; de Sanjose S; Alemany L; Olaitan A; Wong M; Jurkovic D; Crosbie EJ; Rosenthal AN; Bjorge L; Zikan M; Dostalek L; Cibula D; Sundstrom K; Dillner J; Costas L; Widschwendter M
Article: GENOME MEDICINE. 2022;14(1):116
The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer
Barrett JE; Sundstrom K; Jones A; Evans I; Wang J; Herzog C; Dillner J; Widschwendter M
Article: JOURNAL OF CLINICAL ONCOLOGY. 2022;40(14):1522-1528
Human Papillomavirus Infection Determines Prognosis in Cervical Cancer
Lei J; Arroyo-Muehr LS; Lagheden C; Eklund C; Kleppe SN; Elfstroem M; Andrae B; Sparen P; Dillner J; Sundstroem K
Article: NATURE COMMUNICATIONS. 2022;13(1):449
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples
Barrett JE; Herzog C; Jones A; Leavy OC; Evans I; Knapp S; Reisel D; Nazarenko T; Kim Y-N; Franchi D; Ryan A; Franks J; Bjorge L; Zikan M; Cibula D; Harbeck N; Colombo N; Dudbridge F; Jones L; Sundstrom K; Dillner J; Radestad AF; Gemzell-Danielsson K; Pashayan N; Widschwendter M
Article: SCIENTIFIC REPORTS. 2021;11(1):18852
Comparison of DNA and RNA sequencing of total nucleic acids from human cervix for metagenomics
Muhr LSA; Dillner J; Ure AE; Sundstrom K; Hultin E
Article: PLOS MEDICINE. 2021;18(8):e1003748
Organized primary human papillomavirus-based cervical screening: A randomized healthcare policy trial
Elfstrom KM; Eklund C; Lamin H; Ohman D; Hortlund M; Elfgren K; Sundstrom K; Dillner J
Article: VIRUSES-BASEL. 2021;13(7):1323
Human Papillomavirus Detection by Whole-Genome Next-Generation Sequencing: Importance of Validation and Quality Assurance Procedures
Muhr LSA; Guerendiain D; Cuschieri K; Sundstrom K
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2021;190(4):506-514
Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs
Vanska S; Luostarinen T; Lagheden C; Eklund C; Kleppe SN; Andrae B; Sparen P; Sundstrom K; Lehtinen M; Dillner J
Article: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2021;17(4):943-949
Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up
Kjaer SK; Nygard M; Sundstrom K; Munk C; Berger S; Dzabic M; Fridrich KE; Waldstrom M; Sorbye SW; Bautista O; Group T; Luxembourg A
Article: PREVENTIVE MEDICINE. 2021;144:106382
Cervical screening in high-income countries: the need for quality assurance, adjunct biomarkers and rational adaptation to HPV vaccination
Sundstrom K; Herweijer E; Wang J
Journal article: OBSTETRICAL & GYNECOLOGICAL SURVEY. 2021;76(1):31-32
HPV Vaccination and the Risk of Invasive Cervical Cancer
Lei J; Ploner A; Elfström KM; Wang J; Roth A; Fang F; Sundström K; Dillner J; Sparén P
Article: PLOS ONE. 2021;16(2):e0247291
Validation of the cobas 6800 human papillomavirus test in primary cervical screening
Sundstrom K; Lamin H; Dillner J
Article: BRITISH JOURNAL OF CANCER. 2020;123(12):1790-1795
Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
Arroyo Muhr LS; Lagheden C; Lei J; Eklund C; Nordqvist Kleppe S; Sparen P; Sundstrom K; Dillner J
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(14):1340-1348
HPV Vaccination and the Risk of Invasive Cervical Cancer
Lei J; Ploner A; Elfstrom KM; Wang J; Roth A; Fang F; Sundstrom K; Dillner J; Sparen P
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2020;99(9):1214-1221
Emergency contraceptive pill use among women in Denmark, Norway and Sweden: Population-based survey
Guleria S; Munk C; Elfstrom KM; Hansen BT; Sundstrom K; Liaw K-L; Nygard M; Kjaer SK
Article: ECLINICALMEDICINE. 2020;23:100401
Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries
Kjaer SK; Nygard M; Sundstrom K; Dillner J; Tryggvadottir L; Munk C; Berger S; Enerly E; Hortlund M; Agustsson AI; Bjelkenkrantz K; Fridrich K; Gudmundsdottir I; Sorbye SW; Bautista O; Group T; Luxembourg A; Marshall JB; Radley D; Yang YS; Badshah C; Saah A
Article: BMC CANCER. 2020;20(1):396
Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
Ejegod DM; Lagheden C; Bhatia R; Pedersen H; Boada EA; Sundstrom K; Cortes J; Bosch Jose FX; Cuschieri K; Dillner J; Bonde J
Article: CONTEMPORARY CLINICAL TRIALS. 2020;92:105996
Use of real-world data for HPV vaccine trial follow-up in the Nordic region
Enerly E; Berger S; Kjar SK; Sundstrom K; Campbell S; Tryggvadottir L; Munk C; Hortlund M; Joshi A; Saah AJ; Nygard M
Article: JOURNAL OF GENERAL VIROLOGY. 2020;101(3):265-270
Sequencing detects human papillomavirus in some apparently HPV-negative invasive cervical cancers
Muhr LSA; Lagheden C; Eklund C; Lei J; Nordqvist-Kleppe S; Sparen P; Sundstrom K; Dillner J
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;146(5):1230-1240
Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening program
Wang J; Elfstrom KM; Andrae B; Kleppe SN; Ploner A; Lei J; Dillner J; Sundstrom K; Sparen P
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2020;222(2):172.e1-172.e12
Incomplete excision of cervical intraepithelial neoplasia as a predictor of the risk of recurrent disease-a 16-year follow-up study
Alder S; Megyessi D; Sundstrom K; Ostensson E; Mints M; Belkic K; Arbyn M; Andersson S
Article: PLOS ONE. 2020;15(8):e0237911
Using machine learning for predicting cervical cancer from Swedish electronic health records by mining hierarchical representations
Weegar R; Sundstrom K
Article: INTERNATIONAL JOURNAL OF CANCER. 2019;145(11):3033-3039
Increasing participation in cervical screening by targeting long-term nonattenders: Randomized health services study
Elfstrom KM; Sundstrom K; Andersson S; Bzhalava Z; Thor AC; Gzoul Z; Ohman D; Lamin H; Eklund C; Dillner J; Tornberg S
Article: CANCER RESEARCH. 2019;79(17):4532-4538
The HPV16 Genome Is Stable in Women Who Progress to In Situ or Invasive Cervical Cancer: A Prospective Population-Based Study
Arroyo-Muhr L-S; Lagheden C; Hultin E; Eklund C; Adami H-O; Dillner J; Sundstrom K
Article: CANCER RESEARCH. 2019;79(15):3965-3972
Psychologic Distress Is Associated with Cancer-Specific Mortality among Patients with Cervical Cancer
Lu D; Andrae B; Valdimarsdottir U; Sundstrom K; Fall K; Sparen P; Fang F
Article: PREVENTIVE MEDICINE. 2019;120:26-33
Mode of HPV vaccination delivery and equity in vaccine uptake: A nationwide cohort study
Wang J; Ploner A; Sparen P; Lepp T; Roth A; Arnheim-Dahlstrom L; Sundstrom K
Article: BMJ OPEN. 2018;8(12):e023789
What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries
Wegwarth O; Widschwendter M; Cibula D; Sundstroem K; Portuesi R; Lein I; Rebitschek FG; Dillner J; Zikan M; Bjorge L; Colombo N; Hadwin R; Harbeck N; Dudbridge F; Steyerberg E; de Beaufort I; Siebert U; Sroczynski G; Leimbach A; Paprotka T; Jones A
Article: BMJ OPEN. 2018;8(10):e024477
Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: a national register-based cohort study
Kreusch T; Wang J; Sparen P; Sundstrom K
Article: BRITISH JOURNAL OF CANCER. 2018;119(9):1163-1168
Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study
Arroyo-Muhr LS; Lagheden C; Hultin E; Eklund C; Adami H-O; Dillner J; Sundstrom K
Article: PLOS MEDICINE. 2018;15(10):e1002666
High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study
Lei J; Ploner A; Lagheden C; Eklund C; Kleppe SN; Andrae B; Elfstrom KM; Dillner J; Sparen P; Sundstrom K
Article: BRITISH JOURNAL OF CANCER. 2018;118(10):1377-1381
Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
Lagheden C; Eklund C; Lamin H; Kleppe SN; Lei J; Elfstrom KM; Sundstrom K; Andrae B; Sparen P; Dillner J
Article: PLOS MEDICINE. 2017;14(10):e1002414
Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden
Wang J; Andrae B; Sundstrom K; Ploner A; Strom P; Elfstrom KM; Dillner J; Sparen P
Article: INTERNATIONAL JOURNAL OF CANCER. 2017;141(1):200-209
Risk stratification in cervical cancer screening by complete screening history: Applying bioinformatics to a general screening population
Baltzer N; Sundstrom K; Nygard JF; Dillner J; Komorowski J
Article: BMJ OPEN. 2017;7(6):e015021
Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study
Lamb F; Herweijer E; Ploner A; Uhnoo I; Sundstrom K; Sparen P; Arnheim-Dahlstrom L
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2017;216(1):48.e1-48.e15
Follow-up of women with cervical cytological abnormalities showing atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion: a nationwide cohort study
Sundstrom K; Lu D; Elfstrom KM; Wang J; Andrae B; Dillner J; Sparen P
Article: JOURNAL OF INTERNAL MEDICINE. 2016;280(6):618-626
Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study
Gronlund O; Herweijer E; Sundstrom K; Arnheim-Dahlstrom L
Article: BMC INFECTIOUS DISEASES. 2016;16(1):419
Sexually transmitted infections after bereavement - a population-based cohort study
Bond E; Lu D; Herweijer E; Sundstrom K; Valdimarsdottir U; Fall K; Arnheim-Dahlstrom L; Sparen P; Fang F
Article: JOURNAL OF CLINICAL VIROLOGY. 2016;80:36-39
ValidatiValidation of a standardized extraction method for formalin-fixed paraffin-embedded tissue samples
Lagheden C; Eklund C; Kleppe SN; Unger ER; Dillner J; Sundstrom K
Article: INTERNATIONAL JOURNAL OF CANCER. 2016;138(12):2867-2874
Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study
Herweijer E; Sundstrom K; Ploner A; Uhnoo I; Sparen P; Arnheim-Dahlstrom L
Article: BMJ-BRITISH MEDICAL JOURNAL. 2016;352:i276
Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study
Wang J; Andrae B; Sundstrom K; Strom P; Ploner A; Elfstrom KM; Arnheim-Dahlstrom L; Dillner J; Sparen P
Article: JOURNAL OF CLINICAL VIROLOGY. 2016;75:33-36
Laboratory audit as part of the quality assessment of a primary HPV-screening program
Hortlund M; Sundstrom K; Lamin H; Hjerpe A; Dillner J
Article: CANCER RESEARCH. 2016;76(3):643-651
Bereavement Is Associated with an Increased Risk of HPV Infection and Cervical Cancer: An Epidemiological Study in Sweden
Lu D; Sundstrom K; Sparen P; Fall K; Sjolander A; Dillner J; Helm NY; Adami H-O; Valdimarsdottir U; Fang F
Article: PLOS ONE. 2016;11(5):e0156215
Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Adenocarcinoma Risk: Nested Case-Control Study
Smelov V; Gheit T; Sundstrom K; Ploner A; McKay-Chopin S; Eklund C; Tommasino M; Dillner J
Article: BMC INFECTIOUS DISEASES. 2015;15:488
Incidence of herpes zoster and associated events including stroke-a population-based cohort study
Sundstrom K; Weibull CE; Soderberg-Lofdal K; Bergstrom T; Sparen P; Arnheim-Dahlstrom L
Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2015;107(10):djv185
Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer
Sundstrom K; Ploner A; Arnheim-Dahlstrom L; Eloranta S; Palmgren J; Adami H-O; Helm NY; Sparen P; Dillner J
Article: ONCOLOGY REPORTS. 2015;33(5):2521-2528
Mothers' acceptance of human papillomavirus (HPV) vaccination for daughters in a country with a high prevalence of HPV
Alder S; Gustafsson S; Perinetti C; Mints M; Sundstrom K; Andersson S
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2015;313(1):54-61
Quadrivalent HPV Vaccination and Risk of Multiple Sclerosis and Other Demyelinating Diseases of the Central Nervous System
Scheller NM; Svanstrom H; Pasternak B; Arnheim-Dahlstrom L; Sundstrom K; Fink K; Hviid A
Article: PLOS ONE. 2015;10(5):e0128270
Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 Years
Ostensson E; Alder S; Elfstrom KM; Sundstrom K; Zethraeus N; Arbyn M; Andersson S
Article: PLOS ONE. 2015;10(7):e0134185
The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study
Herweijer E; Feldman AL; Ploner A; Arnheim-Dahlstrom L; Uhnoo I; Netterlid E; Dillner J; Sparen P; Sundstrom K
Article: AMIA ... ANNUAL SYMPOSIUM PROCEEDINGS / AMIA SYMPOSIUM. AMIA SYMPOSIUM. 2015;2015:1296-1305
Finding Cervical Cancer Symptoms in Swedish Clinical Text using a Machine Learning Approach and NegEx.
Weegar R; Kvist M; Sundström K; Brunak S; Dalianis H
Journal article: PLOS ONE. 2015;10(8):e0135534
Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 Years (vol 10, e0128270, 2015)
Oestensson E; Alder S; Elfstroem KM; Sundstroem K; Zethraeus N; Arbyn M; Andersson S
Article: CANCER CAUSES & CONTROL. 2014;25(4):499-506
Loss of a parent and the risk of cancer in early life: a nationwide cohort study
Kennedy B; Valdimarsdottir U; Sundstrom K; Sparen P; Lambe M; Fall K; Fang F
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2013;43(4):1310-1318
Acceptance of human papillomavirus (HPV) vaccination among young women in a country with a high prevalence of HPV infection
Alder S; Perinetti C; Mints M; Belkic K; Sundstrom K; Sandin S; Weiderpass E; Andersson S
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2013;22(1):150-158
Prospective Study of HPV16 Viral Load and Risk of In Situ and Invasive Squamous Cervical Cancer
Sundstrom K; Ploner A; Dahlstrom LA; Palmgren J; Dillner J; Adami H-O; Ylitalo N; Sparen P
Article: JOURNAL OF ADOLESCENT HEALTH. 2012;50(2):204-206
Awareness and Knowledge of Human Papillomavirus in the Swedish Adult Population
Dahlstrom LA; Sundstrom K; Young C; Lundholm C; Sparen P; Tran TN
Article: PLOS ONE. 2011;6(6):e20624
Assessing Perceived Risk and STI Prevention Behavior: A National Population-Based Study with Special Reference to HPV
Leval A; Sundstrom K; Ploner A; Dahlstrom LA; Widmark C; Sparen P
Article: VACCINE. 2010;28(47):7492-7500
Acceptability of HPV vaccination among young adults aged 18-30 years-a population based survey in Sweden
Sundstrom K; Tran TN; Lundholm C; Young C; Sparen P; Dahlstrom LA
Article: INTERNATIONAL JOURNAL OF CANCER. 2010;127(8):1923-1930
Prospective study of human papillomavirus and risk of cervical adenocarcinoma
Dahlstrom LA; Ylitalo N; Sundstrom K; Palmgren J; Ploner A; Eloranta S; Sanjeevi CB; Andersson S; Rohan T; Dillner J; Adami H-O; Sparen P
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2010;19(10):2469-2478
Prospective Study of Human Papillomavirus (HPV) Types, HPV Persistence, and Risk of Squamous Cell Carcinoma of the Cervix
Sundstrom K; Eloranta S; Sparen P; Dahlstrom LA; Gunnell A; Lindgren A; Palmgren J; Ploner A; Sanjeevi CB; Melbye M; Dillner J; Adami H-O; Ylitalo N
Article: INTERNATIONAL JOURNAL OF CANCER. 2010;126(2):500-507
Attitudes to HPV vaccination among parents of children aged 12-15 years-a population-based survey in Sweden
Dahlstrom LA; Tran TN; Lundholm C; Young C; Sundstrom K; Sparen P
Article: LAKARTIDNINGEN. 2009;106(17):1182-1185
[Helicopters in health care can solve the logistics and strengthen the competence].
Sundstrom K; Svensén C
Visa fler

Alla övriga publikationer

Review: EXPERT REVIEW OF VACCINES. 2023;22(1):161-179
A review of data systems for assessing the impact of HPV vaccination in selected high-income countries
Wang WV; Kothari S; Khoury H; Niccolai L; Garland SM; Sundstrom K; de Pouvourville G; Bonanni P; Chen Y-T; Franco EL
Conference publication: ANNALS OF ONCOLOGY. 2023;34:s538
Mental and socioeconomic burden in endometrial and cervical cancer patients: A Swedish population-based study of survivorship
Wang J; Feldman AL; Bencina G; Andersson M; Salomonsson S; Fang F; Sundstrom K
Review: EXPERT REVIEW OF VACCINES. 2022;21(12):1799-1817
Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review
Wang WV; Kothari S; Skufca J; Giuliano AR; Sundstrom K; Nygard M; Koro C; Baay M; Verstraeten T; Luxembourg A; Saah AJ; Garland SM
Review: EXPERT REVIEW OF VACCINES. 2022;21(2):227-240
Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources
Wang W; Kothari S; Baay M; Garland SM; Giuliano AR; Nygard M; Velicer C; Tota J; Sinha A; Skufca J; Verstraeten T; Sundstrom K
Preprint: SSRN ELECTRONIC JOURNAL. 2022
Human Papillomavirus Types in Invasive Cervical Cancer in Relation to Cervical Screening
Wang J; Elfström KM; Lagheden C; Eklund C; Sundström K; Sparén P; Dillner J
Editorial comment: JOURNAL OF INFECTIOUS DISEASES. 2021;223(9):1510-1511
How Many Human Papillomavirus Types Do We Need to Screen For?
Sundstrom K; Dillner J
Preprint: RESEARCH SQUARE. 2020
Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
Ejegod DM; Lagheden C; Bhatia R; Pedersen H; Boada EA; Sundström K; Cortés J; Josë FXB; Cuschieri K; Dillner J; Bonde J
Editorial comment: CANCER. 2020;126(8):1602-1604
More evidence suggesting that 1-dose human papillomavirus vaccination may be effective
Brotherton JML; Sundstrom K
Preprint: RESEARCH SQUARE. 2020
Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
Ejegod DM; Lagheden C; Bhatia R; Pedersen H; Boada EA; Sundström K; Cortés J; Josë FXB; Cuschieri K; Dillner J; Bonde J
Preprint: RESEARCH SQUARE. 2020
Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
Ejegod DM; Lagheden C; Bhatia R; Pedersen H; Boada EA; Sundström K; Cortés J; Josë FXB; Cuschieri K; Dillner J; Bonde J
Editorial comment: PLOS MEDICINE. 2020;17(1):e1003035
Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?
Sundstrom K; Elfstrom KM
Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(15):5525
Human papillomavirus genotype and prognosis of invasive cervical cancer: A nationwide cohort study.
Lei J; Ploner A; Lagheden C; Eklund C; Kleppe SN; Andrae B; Elfstrom KM; Dillner J; Sparen P; Sundstrom K
Review: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27(11):1159-1165
Differential uptake of herpes zoster vaccination associated with socioeconomic status: A population-based study in Stockholm County, Sweden
Fogelberg S; Lamb F; Gronlund O; Eriksson I; Sundstrom K; Clements M; Arnheim-Dahlstrom L
Conference publication: 2018 IEEE 14TH INTERNATIONAL CONFERENCE ON E-SCIENCE (E-SCIENCE 2018). 2018;:288-289
Stratifying Cervical Cancer Risk With Registry Data
Baltzer N; Sundstrom K; Nygard J; Nygard M; Dillner J; Komorowski J
Review: NATURE REVIEWS CLINICAL ONCOLOGY. 2018;15(5):292-309
Epigenome-based cancer risk prediction: rationale, opportunities and challenges
Widschwendter M; Jones A; Evans I; Reiser D; Dillner J; Sundstrom K; Steyerberg EW; Vergouwe Y; Wegwarth O; Rebitschek FG; Siebert U; Sroczynski G; de Beaufort ID; Bolt I; Cibula D; Zikan M; Bjorge L; Colombo N; Harbeck N; Dudbridge F; Tasse A-M; Knoppers BM; Joly Y; Teschendorff AE; Pashayan N
Letter: INTERNATIONAL JOURNAL OF CANCER. 2017;141(2):416-418
Untitled Reply
Sundstrom K; Herweijer E; Sparen P; Ploner A
Letter: JOURNAL OF INTERNAL MEDICINE. 2017;281(3):311-312
Authors' response: Letter to the Editor - HPV vaccine and autoimmunity
Gronlund O; Herweijer E; Sundstrom K; Arnheim-Dahlstrom L
Review: CURRENT OPINION IN ONCOLOGY. 2014;26(1):120-129
Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review
Elfstrom KM; Herweijer E; Sundstrom K; Arnheim-Dahlstrom L
Doctoral thesis: 2012
Human papillomavirus test and vaccination : impact on cervical cancer screening and prevention
Sundström K

Anställningar

Senior Forskare, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2023-

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2013
Läkarexamen, Karolinska Institutet, 2009

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI